Announcement of net asset value of INVL Baltic Real Estate on 31 March 2025

Click here - to use the wp menu builder

News Room

Less than 1 min.Read

By Investing Today

April 30, 2025

The net asset value of INVL Baltic Real Estate, as provided in the Articles of Association section XI ‘Valuation of assets of the company and calculation of the net asset value’, amounted to EUR 25,388,886 or EUR 3.1920 per share on 31 March 2025.

The person authorized to provide additional information:
Real Estate Fund Manager of Management Company
Vytautas Bakšinskas
E-mail [email protected]

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

INVL Baltic Real Estate Interim unaudited information for 3 months of 2025

Denny’s Celebrates Scholars with Prestigious Hungry for Education™ Scholarship Awards

Announcement of net asset value of INVL Baltic Real Estate on 31 March 2025

Equinor sells the Peregrino field for USD 3.5 billion

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with...

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Landsea Homes Schedules First Quarter 2025 Earnings Release and Conference Call

Topics

Equinor sells the Peregrino field for USD 3.5 billion

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with...

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Landsea Homes Schedules First Quarter 2025 Earnings Release and Conference Call

EZCORP Announces Retirement of $103.4 Million Convertible Notes

Petrus Resources Declares Monthly Dividend for May 2025

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Related Articles

Equinor sells the Peregrino field for USD 3.5 billion

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with...

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Landsea Homes Schedules First Quarter 2025 Earnings Release and Conference Call

Company

Headlines

Equinor sells the Peregrino field for USD 3.5 billion

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with...

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Newsletter